159 related articles for article (PubMed ID: 38773976)
1. Comprehensive multi-omics analysis of pyroptosis for optimizing neoadjuvant immunotherapy in patients with gastric cancer.
Wang JB; Gao YX; Ye YH; Zheng QL; Luo HY; Wang SH; Zhang T; Jin QW; Zheng CH; Li P; Lin JX; Chen QY; Cao LL; Yang YH; Huang CM; Xie JW
Theranostics; 2024; 14(7):2915-2933. PubMed ID: 38773976
[No Abstract] [Full Text] [Related]
2. Development and verification of a manganese metabolism- and immune-related genes signature for prediction of prognosis and immune landscape in gastric cancer.
Han X; Leng C; Zhao S; Wang S; Chen S; Wang S; Zhang M; Li X; Lu Y; Wang B; Qi W
Front Immunol; 2024; 15():1377472. PubMed ID: 38807601
[TBL] [Abstract][Full Text] [Related]
3. Construction of a TAN-associated risk score model with integrated multi-omics data analysis and clinical validation in gastric cancer.
Xu Z; Zhang L; Wang X; Pan B; Zhu M; Wang T; Xu W; Li L; Wei Y; Wu J; Zhou X
Life Sci; 2024 Jul; 349():122731. PubMed ID: 38782354
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive characterization of pyroptosis phenotypes with distinct tumor immune profiles in gastric cancer to aid immunotherapy.
Huang K; Lin Y; Qiu G; Wang S; Feng L; Zheng Z; Gao Y; Fan X; Zheng W; Zhuang J; Luo F; Feng S
Aging (Albany NY); 2023 Aug; 15(16):8113-8136. PubMed ID: 37595258
[TBL] [Abstract][Full Text] [Related]
5. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning.
Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z
Front Immunol; 2021; 12():685992. PubMed ID: 34262565
[TBL] [Abstract][Full Text] [Related]
6. Tumor Immunophenotyping-Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer.
Wang JB; Qiu QZ; Zheng QL; Zhao YJ; Xu Y; Zhang T; Wang SH; Wang Q; Jin QW; Ye YH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Yang YH; Zheng CH; Huang CM
Adv Sci (Weinh); 2023 May; 10(15):e2207417. PubMed ID: 36998102
[TBL] [Abstract][Full Text] [Related]
7. Pyroptosis Patterns Characterized by Distinct Tumor Microenvironment Infiltration Landscapes in Gastric Cancer.
Xiang R; Ge Y; Song W; Ren J; Kong C; Fu T
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680930
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
[TBL] [Abstract][Full Text] [Related]
9. Tumor purity as a prognosis and immunotherapy relevant feature in gastric cancer.
Gong Z; Zhang J; Guo W
Cancer Med; 2020 Dec; 9(23):9052-9063. PubMed ID: 33030278
[TBL] [Abstract][Full Text] [Related]
10. Correlations between the modification patterns mediated by pyroptosis-related genes, tumor microenvironment, and immunotherapy in soft tissue sarcoma.
Cai Y; Meng J; Qiu Y; Huang X; Du H; Yao J
Medicine (Baltimore); 2024 May; 103(20):e38173. PubMed ID: 38758862
[TBL] [Abstract][Full Text] [Related]
11. Exploring the role of pyroptosis in shaping the tumor microenvironment of colorectal cancer by bulk and single-cell RNA sequencing.
Ding C; Yang X; Li S; Zhang E; Fan X; Huang L; He Z; Sun J; Ma J; Zang L; Zheng M
Cancer Cell Int; 2023 May; 23(1):95. PubMed ID: 37198617
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive multi-omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial.
Zhao Y; Li D; Zhuang J; Li Z; Xia Q; Li Z; Yu J; Wang J; Zhang Y; Li K; Xu S; Li S; Ma P; Cao Y; Liu C; Xu C; Liu Z; Wei J; Zhang C; Qiao L; Gao X; Hou Z; Liu C; Zheng R; Wang D; Liu Y
Clin Transl Med; 2024 May; 14(5):e1674. PubMed ID: 38685486
[TBL] [Abstract][Full Text] [Related]
13. TM-Score predicts immunotherapy efficacy and improves the performance of the machine learning prognostic model in gastric cancer.
Xiang K; Zhang M; Yang B; Liu X; Wang Y; Liu H; Song Y; Yuan Y; Zhang L; Wen T; Zhang GW
Int Immunopharmacol; 2024 Jun; 134():112224. PubMed ID: 38723370
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of pyroptosis-related gene landscape in prognosis and immunotherapy of ovarian cancer.
Gao L; Ying F; Cai J; Peng M; Xiao M; Sun S; Zeng Y; Xiong Z; Cai L; Gao R; Wang Z
J Ovarian Res; 2023 Jan; 16(1):27. PubMed ID: 36707884
[TBL] [Abstract][Full Text] [Related]
15. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
[TBL] [Abstract][Full Text] [Related]
16. GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration.
Zhao W; Liang Z; Yao Y; Ge Y; An G; Duan L; Yao J
Cancer Immunol Immunother; 2024 May; 73(7):131. PubMed ID: 38748299
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer.
Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C
Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494
[TBL] [Abstract][Full Text] [Related]
18. Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis.
Zhao S; Liu Y; Ding L; Zhang C; Ye J; Sun K; Song W; Cai S; He Y; Peng J; Xu J
J Pathol Clin Res; 2024 May; 10(3):e12378. PubMed ID: 38778559
[TBL] [Abstract][Full Text] [Related]
19. Multi-omics characteristics of tumor-associated macrophages in the tumor microenvironment of gastric cancer and their exploration of immunotherapy potential.
Cao F; Liu Y; Cheng Y; Wang Y; He Y; Xu Y
Sci Rep; 2023 Oct; 13(1):18265. PubMed ID: 37880233
[TBL] [Abstract][Full Text] [Related]
20. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
